9II9
Crystal structure of SARS-CoV-2 neutralizing antibody K4-66
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SPRING-8 BEAMLINE BL41XU |
Synchrotron site | SPring-8 |
Beamline | BL41XU |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2024-01-29 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 1.0 |
Spacegroup name | P 41 21 2 |
Unit cell lengths | 147.450, 147.450, 154.930 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 49.410 - 2.900 |
R-factor | 0.2637 |
Rwork | 0.262 |
R-free | 0.28850 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.003 |
RMSD bond angle | 0.606 |
Data reduction software | ADDREF |
Data scaling software | XDS |
Phasing software | MOLREP |
Refinement software | REFMAC (1.20.1_4487) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 49.410 | 2.900 |
High resolution limit [Å] | 2.830 | 2.830 |
Number of reflections | 41387 | 6519 |
<I/σ(I)> | 13.58 | |
Completeness [%] | 100.0 | |
Redundancy | 81.5 | |
CC(1/2) | 0.998 | 0.564 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7 | 293 | 0.1M HEPES pH 7.0-7.5, 16.5-19.0% polyethylene glycol 20000 |